Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 3/2015

01.03.2015 | Retinal Disorders

Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy

verfasst von: Kazunari Hirota, Hiroshi Keino, Makoto Inoue, Hitoshi Ishida, Akito Hirakata

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

MicroRNAs (miRNAs) are small noncoding RNAs which regulate the activities of target mRNAs. We compared the expression profiles of the miRNAs in the vitreous of eyes with macular hole (MH) to that in eyes with proliferative diabetic retinopathy (PDR).

Methods

Vitreous and whole blood samples were collected from four patients with MH and from four patients with PDR. We assayed for 168 miRNAs in the vitreous and serum samples by the microRNA PCR Panel method.

Results

The mean number of miRNAs expressed in the vitreous was 63 (55–69) in eyes with MH and 86 (65–117) in eyes with PDR. The mean number of miRNAs expressed in the serum was 162 (159–167) in the MH patients and 142 (115–160) in the PDR patients. Twenty-six miRNAs were expressed in the vitreous of both MH and PDR eyes. Although there was no significant difference in the levels of 20 of the 26 (73 %) miRNAs expressed in both MH and PDR eyes, six of 26 miRNAs (24 %) (hsa-miR-15a, hsa-miR320a, hsa-miR-320b, hsa-miR-93, hsa-miR-29a, and hsa-miR-423-5p) were expressed significantly more highly in PDR eyes. In addition, the mean fold changes of three miRNAs, hsa-miR-23a, hsa-miR-320a, and hsa-miR-320b, in the vitreous to serum were significantly higher in the PDR group than in the MH group.

Conclusions

The expression of several miRNAs related to angiogenesis and fibrosis was expressed significantly higher in the vitreous of eyes with PDR. Further studies are needed to understand the role played by the miRNAs in the biological function of the eye.
Literatur
1.
Zurück zum Zitat Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139CrossRefPubMed Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139CrossRefPubMed
2.
Zurück zum Zitat Kanwar JR, Mahidhara G, Kanwar RK (2010) MicroRNA in human cancer and chronic inflammatory diseases. Front Biosci 2:1113–1126 Kanwar JR, Mahidhara G, Kanwar RK (2010) MicroRNA in human cancer and chronic inflammatory diseases. Front Biosci 2:1113–1126
5.
Zurück zum Zitat Boon RA (2012) MicroRNAs control vascular endothelial growth factor signaling. Circ Res 111:1388–1390CrossRefPubMed Boon RA (2012) MicroRNAs control vascular endothelial growth factor signaling. Circ Res 111:1388–1390CrossRefPubMed
6.
Zurück zum Zitat Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C (2012) Circulating microRNAs; new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 41:1897–1912PubMed Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C (2012) Circulating microRNAs; new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 41:1897–1912PubMed
7.
Zurück zum Zitat Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA (2011) MicroRNAs in body fluids–the mix of hormones and biomarkers. Nat Rev Clin Oncol 8:467–477CrossRefPubMedCentralPubMed Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA (2011) MicroRNAs in body fluids–the mix of hormones and biomarkers. Nat Rev Clin Oncol 8:467–477CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Ragusa M, Caltabiano R, Russo A, Puzzo A, Avitabile T, Longo A, Toro MD, Di Pietro C, Purrello M, Reibaldi M (2013) MicroRNAs in vitreous humor from patients with ocular diseases. Mol Vis 19:430–440PubMedCentralPubMed Ragusa M, Caltabiano R, Russo A, Puzzo A, Avitabile T, Longo A, Toro MD, Di Pietro C, Purrello M, Reibaldi M (2013) MicroRNAs in vitreous humor from patients with ocular diseases. Mol Vis 19:430–440PubMedCentralPubMed
9.
Zurück zum Zitat Tuo J, Shen D, Yang HH, Chan CC (2014) Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis. Am J Ophthalmol 15:728–734CrossRef Tuo J, Shen D, Yang HH, Chan CC (2014) Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis. Am J Ophthalmol 15:728–734CrossRef
10.
Zurück zum Zitat Fong DS, Aiello LP, Ferris FL 3rd, Klein R (2004) Diabetic retinopathy. Diabetes Care 27:2540–2553CrossRefPubMed Fong DS, Aiello LP, Ferris FL 3rd, Klein R (2004) Diabetic retinopathy. Diabetes Care 27:2540–2553CrossRefPubMed
11.
Zurück zum Zitat Salam A, Mathew R, Sivaprasad S (2011) Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Opthalmol 89:405–411CrossRef Salam A, Mathew R, Sivaprasad S (2011) Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Opthalmol 89:405–411CrossRef
13.
Zurück zum Zitat Schraermeyer U, Julien S (2013) Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes. Expert Opin Biol Ther 13:157–167CrossRefPubMed Schraermeyer U, Julien S (2013) Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes. Expert Opin Biol Ther 13:157–167CrossRefPubMed
15.
Zurück zum Zitat Yin KJ, Olsen K, Hamblin M, Zhang J, Schwendeman SP, Chen YE (2012) Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia. J Biol Chem 287:27055–27064CrossRefPubMedCentralPubMed Yin KJ, Olsen K, Hamblin M, Zhang J, Schwendeman SP, Chen YE (2012) Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia. J Biol Chem 287:27055–27064CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM (2009) MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36:181–188CrossRefPubMed Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM (2009) MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36:181–188CrossRefPubMed
17.
Zurück zum Zitat Long J, Wang Y, Wang W, Chang BH, Danesh FR (2010) Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 285:23457–23465CrossRefPubMedCentralPubMed Long J, Wang Y, Wang W, Chang BH, Danesh FR (2010) Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 285:23457–23465CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Xhang JP, Guan XY, Zhuang SM (2011) MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 54:1729–1740CrossRefPubMed Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Xhang JP, Guan XY, Zhuang SM (2011) MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 54:1729–1740CrossRefPubMed
19.
Zurück zum Zitat Wu YY, Chen YL, Jao YC, Hsieh IS, Chang KC, Hong TM (2014) MiR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1. Angiogenesis 17:247–260CrossRefPubMed Wu YY, Chen YL, Jao YC, Hsieh IS, Chang KC, Hong TM (2014) MiR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1. Angiogenesis 17:247–260CrossRefPubMed
21.
Zurück zum Zitat Zhao Y, Xu Y, Luo F, Xu W, Wang B, Pang Y, Zhou J, Wang X, Liu Q (2013) Angiogenesis, mediated by miR-21, is involved arsenite-induced carcinogenesis. Toxicol Lett 223:35–41CrossRefPubMed Zhao Y, Xu Y, Luo F, Xu W, Wang B, Pang Y, Zhou J, Wang X, Liu Q (2013) Angiogenesis, mediated by miR-21, is involved arsenite-induced carcinogenesis. Toxicol Lett 223:35–41CrossRefPubMed
22.
23.
Zurück zum Zitat Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, Yang W, Hou FF, Lan HY (2013) MiR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56:663–674CrossRefPubMed Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, Yang W, Hou FF, Lan HY (2013) MiR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56:663–674CrossRefPubMed
24.
Zurück zum Zitat Wang J, Gao Y, Ma M, Li M, Zou D, Yang J, Zhu Z, Zhao X (2013) Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem Biophys 67:537–546CrossRefPubMed Wang J, Gao Y, Ma M, Li M, Zou D, Yang J, Zhu Z, Zhao X (2013) Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem Biophys 67:537–546CrossRefPubMed
25.
Zurück zum Zitat Fiorentino L, Cavalera M, Mavilio M, Conserva F, Menghini R, Gesualdo L, Federici M (2013) Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta Diabetol 50:965–969CrossRefPubMed Fiorentino L, Cavalera M, Mavilio M, Conserva F, Menghini R, Gesualdo L, Federici M (2013) Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta Diabetol 50:965–969CrossRefPubMed
26.
Zurück zum Zitat Zhong X, Chung AC, Chen HY, Meng XM, Lan HY (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22:1668–1681CrossRefPubMedCentralPubMed Zhong X, Chung AC, Chen HY, Meng XM, Lan HY (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22:1668–1681CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat Guduric-Fuchs J, O’Connor A, Cullen A, Harwood L, Medina RJ, O’Neill CL, Stitt AW, Curtis TM, Simpson DA (2012) Deep sequencing reveals predominant expression of miR-21 amongst the small non-coding RNAs in retinal microvascular endothelial cells. J Cell Biochem 113:2098–2111CrossRefPubMedCentralPubMed Guduric-Fuchs J, O’Connor A, Cullen A, Harwood L, Medina RJ, O’Neill CL, Stitt AW, Curtis TM, Simpson DA (2012) Deep sequencing reveals predominant expression of miR-21 amongst the small non-coding RNAs in retinal microvascular endothelial cells. J Cell Biochem 113:2098–2111CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S (2011) Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23 ∼ 27 ∼ 24 clusters. Proc Natl Acad Sci U S A 108:8287–8292CrossRefPubMedCentralPubMed Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S (2011) Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23 ∼ 27 ∼ 24 clusters. Proc Natl Acad Sci U S A 108:8287–8292CrossRefPubMedCentralPubMed
Metadaten
Titel
Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy
verfasst von
Kazunari Hirota
Hiroshi Keino
Makoto Inoue
Hitoshi Ishida
Akito Hirakata
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 3/2015
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-014-2692-5

Weitere Artikel der Ausgabe 3/2015

Graefe's Archive for Clinical and Experimental Ophthalmology 3/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.